{"rows":[{"id":5951,"title":"Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice","authors":"Hogg D, Romanos J, Albiez J, Hofer C, Wicki S, Argunşah A, Sigrist H, Thomann J, Luethi D, Vollenweider F, Pryce C.","journal":"Frontiers in pharmacology","publication_date":"2026-10-07","publication_year":2026,"doi":"10.3389/fphar.2026.1918182","pubmed_id":null,"openalex_id":"https://openalex.org/W7213965271","source_url":"https://europepmc.org/article/PMC/PMC13639876","substance_tags":"psilocybin","topic_tags":"Animal Study","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-23 01:20:24","last_checked":"2026-10-09 01:20:16","bibtex":null,"source_record_id":"DOI:10.3389/fphar.2026.1918182","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://europepmc.org/article/PMC/PMC13639876","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.3389/fphar.2026.1918182","source_url":"https://europepmc.org/article/PMC/PMC13639876","doi":"10.3389/fphar.2026.1918182","pmid":"","publication_date":"2026-10-07","importer_version":"2.1.3","text_redistributed":false}},{"id":5151,"title":"The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.","authors":"Dudysová D, Janků K, Šmotek M, Saifutdinova E, Kopřivová J, Bušková J, Mander BA, Brunovský M, Zach P, Korčák J, Andrashko V, Viktorinová M, Tylš F, Bravermanová A, Froese T, Páleníček T, Horáček J","journal":"Frontiers in pharmacology","publication_date":"2020-01-01","publication_year":2020,"doi":"10.3389/fphar.2020.602590","pubmed_id":"33343372","openalex_id":"https://openalex.org/W3107150606","source_url":"https://pubmed.ncbi.nlm.nih.gov/33343372/","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Healthy Volunteers","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:52:00","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33343372","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33343372/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33343372","source_url":"https://pubmed.ncbi.nlm.nih.gov/33343372/","doi":"10.3389/fphar.2020.602590","pmid":"33343372","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2448,"title":"LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.","authors":"Kraehenmann R, Pokorny D, Aicher H, Preller KH, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX","journal":"Frontiers in pharmacology","publication_date":"2017-01-01","publication_year":2017,"doi":"10.3389/fphar.2017.00814","pubmed_id":"29167644","openalex_id":"https://openalex.org/W2768082096","source_url":"https://pubmed.ncbi.nlm.nih.gov/29167644/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Consciousness,Emotional Processing","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:29167644","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29167644/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29167644","source_url":"https://pubmed.ncbi.nlm.nih.gov/29167644/","doi":"10.3389/fphar.2017.00814","pmid":"29167644","publication_date":"2017-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2431,"title":"Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.","authors":"Roseman L, Nutt DJ, Carhart-Harris RL","journal":"Frontiers in pharmacology","publication_date":"2017-01-01","publication_year":2017,"doi":"10.3389/fphar.2017.00974","pubmed_id":"29387009","openalex_id":"https://openalex.org/W2792444257","source_url":"https://pubmed.ncbi.nlm.nih.gov/29387009/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Drug Interactions","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:29387009","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29387009/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29387009","source_url":"https://pubmed.ncbi.nlm.nih.gov/29387009/","doi":"10.3389/fphar.2017.00974","pmid":"29387009","publication_date":"2017-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2423,"title":"Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.","authors":"Bogenschutz MP, Podrebarac SK, Duane JH, Amegadzie SS, Malone TC, Owens LT, Ross S, Mennenga SE","journal":"Frontiers in pharmacology","publication_date":"2018-01-01","publication_year":2018,"doi":"10.3389/fphar.2018.00100","pubmed_id":"29515439","openalex_id":"https://openalex.org/W2788524689","source_url":"https://pubmed.ncbi.nlm.nih.gov/29515439/","substance_tags":"psilocybin","topic_tags":"Addiction,Consciousness,Mystical Experience,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:29515439","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29515439/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29515439","source_url":"https://pubmed.ncbi.nlm.nih.gov/29515439/","doi":"10.3389/fphar.2018.00100","pmid":"29515439","publication_date":"2018-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2422,"title":"The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.","authors":"Nielson EM, May DG, Forcehimes AA, Bogenschutz MP","journal":"Frontiers in pharmacology","publication_date":"2018-01-01","publication_year":2018,"doi":"10.3389/fphar.2018.00132","pubmed_id":"29515449","openalex_id":"https://openalex.org/W2793096639","source_url":"https://pubmed.ncbi.nlm.nih.gov/29515449/","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:29515449","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29515449/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29515449","source_url":"https://pubmed.ncbi.nlm.nih.gov/29515449/","doi":"10.3389/fphar.2018.00132","pmid":"29515449","publication_date":"2018-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2420,"title":"Unifying Theories of Psychedelic Drug Effects.","authors":"Swanson LR","journal":"Frontiers in pharmacology","publication_date":"2018-01-01","publication_year":2018,"doi":"10.3389/fphar.2018.00172","pubmed_id":"29568270","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/29568270/","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Emotional Processing,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:29568270","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29568270/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29568270","source_url":"https://pubmed.ncbi.nlm.nih.gov/29568270/","doi":"10.3389/fphar.2018.00172","pmid":"29568270","publication_date":"2018-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2413,"title":"Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.","authors":"Malone TC, Mennenga SE, Guss J, Podrebarac SK, Owens LT, Bossis AP, Belser AB, Agin-Liebes G, Bogenschutz MP, Ross S","journal":"Frontiers in pharmacology","publication_date":"2018-01-01","publication_year":2018,"doi":"10.3389/fphar.2018.00256","pubmed_id":"29666578","openalex_id":"https://openalex.org/W2796179442","source_url":"https://pubmed.ncbi.nlm.nih.gov/29666578/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Cancer Patients,Healthcare Workers","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:29666578","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/29666578/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:29666578","source_url":"https://pubmed.ncbi.nlm.nih.gov/29666578/","doi":"10.3389/fphar.2018.00256","pmid":"29666578","publication_date":"2018-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2397,"title":"Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.","authors":"Schenberg EE","journal":"Frontiers in pharmacology","publication_date":"2018-01-01","publication_year":2018,"doi":"10.3389/fphar.2018.00733","pubmed_id":"30026698","openalex_id":"https://openalex.org/W2831064708","source_url":"https://pubmed.ncbi.nlm.nih.gov/30026698/","substance_tags":"psilocybin","topic_tags":"Consciousness,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:30026698","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/30026698/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:30026698","source_url":"https://pubmed.ncbi.nlm.nih.gov/30026698/","doi":"10.3389/fphar.2018.00733","pmid":"30026698","publication_date":"2018-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2195,"title":"The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.","authors":"Winkelman MJ","journal":"Frontiers in pharmacology","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fphar.2021.619890","pubmed_id":"33732156","openalex_id":"https://openalex.org/W3129584613","source_url":"https://pubmed.ncbi.nlm.nih.gov/33732156/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Personality Change,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33732156","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33732156/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33732156","source_url":"https://pubmed.ncbi.nlm.nih.gov/33732156/","doi":"10.3389/fphar.2021.619890","pmid":"33732156","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2194,"title":"Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.","authors":"Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM","journal":"Frontiers in pharmacology","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fphar.2021.640241","pubmed_id":"33716753","openalex_id":"https://openalex.org/W3134320342","source_url":"https://pubmed.ncbi.nlm.nih.gov/33716753/","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Microdosing,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33716753","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33716753/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33716753","source_url":"https://pubmed.ncbi.nlm.nih.gov/33716753/","doi":"10.3389/fphar.2021.640241","pmid":"33716753","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1906,"title":"Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis.","authors":"Basedow LA, Riemer TG, Reiche S, Kreutz R, Majić T","journal":"Frontiers in pharmacology","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fphar.2021.739966","pubmed_id":"34603053","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/34603053/","substance_tags":"psilocybin","topic_tags":"Addiction,Receptor Pharmacology,Consciousness,Meta-Analysis,Systematic Review,Review Article","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:06","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34603053","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34603053/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34603053","source_url":"https://pubmed.ncbi.nlm.nih.gov/34603053/","doi":"10.3389/fphar.2021.739966","pmid":"34603053","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1903,"title":"The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.","authors":"Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M","journal":"Frontiers in pharmacology","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fphar.2021.739053","pubmed_id":"34658876","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/34658876/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Receptor Pharmacology,Aging,Meta-Analysis,Review Article","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:06","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34658876","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34658876/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34658876","source_url":"https://pubmed.ncbi.nlm.nih.gov/34658876/","doi":"10.3389/fphar.2021.739053","pmid":"34658876","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1832,"title":"Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.","authors":"Markopoulos A, Inserra A, De Gregorio D, Gobbi G","journal":"Frontiers in pharmacology","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fphar.2021.749068","pubmed_id":"35177979","openalex_id":"https://openalex.org/W4210379385","source_url":"https://pubmed.ncbi.nlm.nih.gov/35177979/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Safety","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:21","bibtex":null,"source_record_id":"PMID:35177979","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35177979/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35177979","source_url":"https://pubmed.ncbi.nlm.nih.gov/35177979/","doi":"10.3389/fphar.2021.749068","pmid":"35177979","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1810,"title":"Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.","authors":"McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS","journal":"Frontiers in pharmacology","publication_date":"2022-01-01","publication_year":2022,"doi":"10.3389/fphar.2022.841648","pubmed_id":"35355714","openalex_id":"https://openalex.org/W4220686675","source_url":"https://pubmed.ncbi.nlm.nih.gov/35355714/","substance_tags":"psilocybin","topic_tags":"Mystical Experience,Healthy Volunteers","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:35355714","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35355714/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35355714","source_url":"https://pubmed.ncbi.nlm.nih.gov/35355714/","doi":"10.3389/fphar.2022.841648","pmid":"35355714","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1802,"title":"Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.","authors":"Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R","journal":"Frontiers in pharmacology","publication_date":"2021-01-01","publication_year":2021,"doi":"10.3389/fphar.2021.788155","pubmed_id":"35431912","openalex_id":"https://openalex.org/W4221001769","source_url":"https://pubmed.ncbi.nlm.nih.gov/35431912/","substance_tags":"psilocybin","topic_tags":"Depression,Emotional Processing,Mystical Experience,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:35431912","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35431912/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35431912","source_url":"https://pubmed.ncbi.nlm.nih.gov/35431912/","doi":"10.3389/fphar.2021.788155","pmid":"35431912","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1754,"title":"Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.","authors":"Vorobyeva N, Kozlova AA","journal":"Frontiers in pharmacology","publication_date":"2022-01-01","publication_year":2022,"doi":"10.3389/fphar.2022.927984","pubmed_id":"35837277","openalex_id":"https://openalex.org/W4283657643","source_url":"https://pubmed.ncbi.nlm.nih.gov/35837277/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:35837277","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35837277/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35837277","source_url":"https://pubmed.ncbi.nlm.nih.gov/35837277/","doi":"10.3389/fphar.2022.927984","pmid":"35837277","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1732,"title":"Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.","authors":"Roseman L, Preller KH, Fotiou E, Winkelman MJ","journal":"Frontiers in pharmacology","publication_date":"2022-01-01","publication_year":2022,"doi":"10.3389/fphar.2022.979764","pubmed_id":"35935854","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/35935854/","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:19","bibtex":null,"source_record_id":"PMID:35935854","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35935854","source_url":"https://pubmed.ncbi.nlm.nih.gov/35935854/","doi":"10.3389/fphar.2022.979764","pmid":"35935854","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1582,"title":"Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice.","authors":"Alper K, Cange J, Sah R, Schreiber-Gregory D, Sershen H, Vinod KY","journal":"Frontiers in pharmacology","publication_date":"2022-01-01","publication_year":2022,"doi":"10.3389/fphar.2022.1074633","pubmed_id":"36686713","openalex_id":"https://openalex.org/W4313585689","source_url":"https://pubmed.ncbi.nlm.nih.gov/36686713/","substance_tags":"psilocybin","topic_tags":"Addiction,Receptor Pharmacology,Animal Study,Drug Interactions","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:17","bibtex":null,"source_record_id":"PMID:36686713","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36686713/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36686713","source_url":"https://pubmed.ncbi.nlm.nih.gov/36686713/","doi":"10.3389/fphar.2022.1074633","pmid":"36686713","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1556,"title":"Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG.","authors":"Chen Y, Liu J, Yao Y, Yan H, Su R","journal":"Frontiers in pharmacology","publication_date":"2023-01-01","publication_year":2023,"doi":"10.3389/fphar.2023.1021729","pubmed_id":"36874002","openalex_id":"https://openalex.org/W4321088596","source_url":"https://pubmed.ncbi.nlm.nih.gov/36874002/","substance_tags":"psilocin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Consciousness,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:17","bibtex":null,"source_record_id":"PMID:36874002","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36874002/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36874002","source_url":"https://pubmed.ncbi.nlm.nih.gov/36874002/","doi":"10.3389/fphar.2023.1021729","pmid":"36874002","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":30,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Frontiers in pharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}